Widespread hypertranscription in aggressive human cancers.

Saved in:
Bibliographic Details
Title: Widespread hypertranscription in aggressive human cancers.
Authors: Zatzman M; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada., Fuligni F; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada., Ripsman R; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada., Suwal T; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Comitani F; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada., Edward LM; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada., Denroche R; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Jang GH; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Notta F; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Gallinger S; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Wallace McCain Centre for Pancreatic Cancer, Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.; Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, Ontario, Canada., Selvanathan SP; Departments of Oncology and Pediatrics, Georgetown University, Washington, DC 20057, USA., Toretsky JA; Departments of Oncology and Pediatrics, Georgetown University, Washington, DC 20057, USA., Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Tabori U; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Huang A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Shlien A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Source: Science advances [Sci Adv] 2022 Nov 25; Vol. 8 (47), pp. eabn0238. Date of Electronic Publication: 2022 Nov 23.
Publication Type: Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2375-2548
DOI:10.1126/sciadv.abn0238